State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 315 actively recruiting studies with Michigan sites out of 315 registered in total. The busiest research areas in Michigan are Advanced Solid Tumors, Triple Negative Breast Cancer, Prostate Cancer. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), Eli Lilly and Company. By stage, Michigan trials break down as Phase 1 (52), Phase 2 (98), Phase 3 (88), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 315 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 315. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumors, Triple Negative Breast Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT06868290 Phase 2
Recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Act...
Condition
ANCA Associated Vasculitis (AAV)
Enrollment
126 pts
Location
United States, Brazil, Israel
Sponsor
Novartis Pharmaceuticals
NCT01356290 Phase 2
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ...
Condition
Medulloblastoma Recurrent
Enrollment
232 pts
Location
United States, Austria, Czechia
Sponsor
Medical University of Vienna
NCT07361497 Phase 3
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiat...
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
850 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06857942 Phase 4
Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following In...
Condition
Psoriasis
Enrollment
200 pts
Location
United States
Sponsor
Eli Lilly and Company
NCT07133308 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With ...
Condition
Alopecia Areata
Enrollment
355 pts
Location
United States, Canada
Sponsor
Sun Pharmaceutical Industries,
NCT07010770 N/A
Recruiting
SMART Therapist Training: A Hybrid Factorial-SMART Design
Condition
Stress Disorders, Post-Traumatic
Enrollment
240 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07006727 Phase 1
Recruiting
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Soli...
Condition
Small Cell Lung Carcinoma
Enrollment
116 pts
Location
United States, Canada, South Korea
Sponsor
Novartis Pharmaceuticals
NCT03418961 Phase 3
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic...
Condition
Cardiotoxicity
Enrollment
491 pts
Location
United States, Puerto Rico, Saudi Arabia
Sponsor
SWOG Cancer Research Network
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Condition
Amblyopia
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT07218146 Phase 3
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With ...
Condition
Small-cell Lung Cancer
Enrollment
480 pts
Location
United States, Austria, China
Sponsor
Zai Lab (Shanghai) Co., Ltd.
NCT07293351 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or...
Condition
Advanced Renal Cell Carcinoma (RCC)
Enrollment
254 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT05076942 Phase 2
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Condition
Vulvar Cancer
Enrollment
157 pts
Location
United States, Netherlands
Sponsor
University Medical Center Gron
NCT07290803 N/A
Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Pati...
Condition
Atopic Dermatitis
Enrollment
1,000 pts
Location
United States, Canada, China
Sponsor
Sanofi
NCT06828770 N/A
Recruiting
Minima Stent System Post- Approval Study (PAS)
Condition
Pulmonary Artery Stenosis
Enrollment
100 pts
Location
United States
Sponsor
Renata Medical
NCT06349473 Phase 1
Recruiting
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604...
Condition
Healthy Participants
Enrollment
31 pts
Location
United States, Canada
Sponsor
Equilibra Bioscience LLC
NCT06657768 Phase 1
Recruiting
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's ...
Condition
Alzheimer Disease
Enrollment
128 pts
Location
United States, Japan
Sponsor
Eli Lilly and Company
NCT05707923 N/A
Recruiting
How Simplified Language Affects Comprehension and Learning in Young Autistic Chi...
Condition
Autism Spectrum Disorder
Enrollment
104 pts
Location
United States
Sponsor
Michigan State University
NCT07339059 Phase 2
Recruiting
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Thera...
Condition
Small Cell Lung Cancer ( SCLC )
Enrollment
35 pts
Location
United States
Sponsor
Bindu R Potugari
NCT07335497 Phase 1, Phase 2
Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Condition
Locally Advanced / Metastatic Solid Tumors
Enrollment
290 pts
Location
United States, Australia, Ireland
Sponsor
Crescent Biopharma, Inc.
NCT06769126 Phase 2
Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extens...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
900 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04159103 Phase 1, Phase 2
Recruiting
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
Condition
Propionic Acidemia
Enrollment
77 pts
Location
United States, Canada, France
Sponsor
ModernaTX, Inc.
NCT05691478 Phase 2, Phase 3
Recruiting
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patient...
Condition
High Grade Osteosarcoma
Enrollment
1,122 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Condition
Acute Myeloid Leukemia
Enrollment
130 pts
Location
United States, Australia, Austria
Sponsor
PedAL BCU, LLC
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05256225 Phase 3
Recruiting
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy fo...
Condition
Endometrial Carcinoma
Enrollment
360 pts
Location
United States, Puerto Rico, South Korea
Sponsor
National Cancer Institute (NCI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology